ecancermedicalscience

Review

A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus

25 Jan 2018
Danielle Crawley, Florence Chamberlain, Hans Garmo, Sarah Rudman, Björn Zethelius, Lars Holmberg, Jan Adolfsson, Par Stattin, Paul Carroll, Mieke Van Hemelrijck

Prostate cancer (PCa) and type two diabetes mellitus (T2DM) are both increasing prevalent conditions and often occur concurrently. However, the relationship between the two is more complex than just two prevalent conditions co-existing. This review systematically explores the literature around the interplay between the two conditions. It covers the impact of pre-existing T2DM on PCa incidence, grade and stage, as well as exploring the impact of T2DM on PCa outcomes and mortality and the interaction between T2DM and PCa treatments.

Related Articles

Brindha Senthil Kumar, Ponnagoundanpudur Sundaramoorthy Kirit, Nachimuthu Senthil Kumar, Shanmuganandam Sumathi, Samuel Lalhruaizela, Lal Hruaitluanga, Lal Hmingliana
Samvel Bardakhchyan, Sona Karamyan, Hovsep Gharadaghyan, Davit Zohrabyan, Liana Safaryan, Armen Avagyan, Lilit Harutyunyan, Vardan Bardakhchyan, Amalya Sargsyan, Mariam Mailyan, Mariam Sargsyan, Elen Baloyan, Nune Karapetyan, Marine Rushanyan, Gohar Mkrtchyan, Sahak Azizyan, Martin Harutyunyan, Gevorg Tamamyan
Roberta Monteiro Batista Sarmento, José Roberto Lapa e Silva, Gustavo Arantes Rosa Maciel, Claudia Ferrer, José Bines
Monali Swain, Sarbani Ghosh-Laskar, Lachlan McDowell, Christina Henson, Pierluigi Bonomo, Sadhana Kannan, Timothy Malouff, Akihiro Homma, Alexander Rühle, Anna Lee, Francesca Caparrotti, James Bates, Jorgen Johansen, Juliette Thariat, Marco Ferrari, Miguel Mayo-Yáñez, Sarah Hamilton, Sue S Yom, Hisham Mehanna, Petr Szturz